Cannabis firm Canopy Growth set to consolidate shares
Canopy Growth Corp. is set to become the latest cannabis producer to consolidate its shares to maintain its listing on the Nasdaq exchange.
Canopy Growth Corp. is set to become the latest cannabis producer to consolidate its shares to maintain its listing on the Nasdaq exchange.
The number of new medical cannabis patients in Israel surged in November, according to the latest available data from the Ministry of Health.
The Netherlands’ cannabis cultivation and distribution experiment is set to kick off Friday in what executives are calling a milestone for the industry in Europe – even though the supply-chain trial is starting years later than originally planned.
Ontario’s government-owned marijuana wholesaler was sitting on more than 500 million Canadian dollars ($367 million) in cash earlier this year, but officials have declined to spell out why the Ontario Cannabis Store held on to that much money rather than remit some of it back to the provincial government earlier.
Government-owned marijuana wholesaler Ontario Cannabis Store is planning to undertake a temporary testing program to address THC inflation, according to a recent email sent to licensed producers and obtained by MJBizDaily.
Australian cannabis production and exports inched higher in 2022 on the back of consistent industry growth, according to new data published by the country’s Office of Drug Control.
Canadian cannabis producer BZAM entered into a definitive agreement to acquire Final Bell Canada from Final Bell Holdings International in an all-stock transaction, the companies announced Wednesday.
Germany’s parliament won’t have an opportunity to put the first phase of the country’s pending cannabis legislation to a vote this year.
Some ingestible cannabis products that Health Canada considers noncompliant with federal rules still appear to be widely available in parts of the country, almost a year after the regulator asked companies to stop selling them to consumers because of concerns about overconsumption of THC.
The Ontario government is proposing a number of significant legislative and regulatory changes to its cannabis framework that it says would combat the illegal market.
Canada’s federal health regulator has approved Jazz Pharmaceuticals Canada’s cannabinoid-based medicine Epidiolex as an adjunctive therapy for certain rare and severe forms of epilepsy, allowing the company to bring to market a clinically tested drug with global sales that dwarf those of the nation’s entire medical cannabis industry
Canadian marijuana producer SNDL and retailer Nova Cannabis have mutually agreed to terminate the agreement they announced late last year to implement a strategic partnership.